Drugging the cancer genome: New challenges of infrequent and combinatorial targets

被引：0
|
作者：
Workman, Paul [1 ]
机构：
[1] Inst Canc Res, Haddow Labs, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England
来源：
CURRENT OPINION IN INVESTIGATIONAL DRUGS | 2007年 / 8卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：445 / 446
页数：2
相关论文
共 50 条
  • [1] DRUGGING THE CANCER GENOME: OPPORTUNITIES AND CHALLENGES
    Workman, P.
    ANNALS OF ONCOLOGY, 2012, 23 : 8 - 8
  • [2] Drugging the 'undruggable' cancer targets
    Dang, Chi V.
    Reddy, E. Premkumar
    Shokat, Kevan M.
    Soucek, Laura
    NATURE REVIEWS CANCER, 2017, 17 (08) : 502 - 508
  • [3] Drugging the 'undruggable' cancer targets
    Chi V. Dang
    E. Premkumar Reddy
    Kevan M. Shokat
    Laura Soucek
    Nature Reviews Cancer, 2017, 17 : 502 - 508
  • [4] Drugging Undruggable Molecular Cancer Targets
    Lazo, John S.
    Sharlow, Elizabeth R.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56, 2016, 56 : 23 - 40
  • [5] Paul Workman: Drugging the Cancer Genome
    Workman, Paul
    TRENDS IN CANCER, 2016, 2 (10): : 544 - 548
  • [6] Covalent inhibitor targets KRasG12C: A new paradigm for drugging the undruggable and challenges ahead
    Li, Hui-yu
    Qi, Wei-liang
    Wang, Yu-xiang
    Meng, Ling-hua
    GENES & DISEASES, 2023, 10 (02) : 403 - 414
  • [7] New targets and challenges in the molecular therapeutics of cancer
    Eastman, Alan
    Perez, Raymond P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (01) : 5 - 14
  • [8] Drugging the Small GTPase Pathways in Cancer Treatment: Promises and Challenges
    Prieto-Dominguez, Nestor
    Parnell, Christopher
    Teng, Yong
    CELLS, 2019, 8 (03)
  • [9] Drugging Challenging Cancer Targets Using Fragment-Based Methods
    Fesik, Stephen W.
    CHEMICAL REVIEWS, 2025,
  • [10] Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments
    Yip, Hon Yan Kelvin
    Papa, Antonella
    CELLS, 2021, 10 (03) : 1 - 30
12345